Andrew R. Allen

Andrew R. Allen, listed as chief executive, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Gritstone bio, Inc., Epizyme, Inc. and Sierra Oncology, Inc. The record holds 8 filings, for trades running from 7 January 2021 to 24 June 2024.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The record was last updated on 26 June 2024 with a transaction in Gritstone bio, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.